Stay updated on Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Locations section now lists multiple Japanese locations (Aichi-ken, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Kanagawa, Mie-ken, Osaka, Saitama, Tokyo) and per-prefecture location subsections were removed; a revision tag shows v3.3.3.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0 on the Study Details page.SummaryDifference0.0%

- Check48 days agoChange DetectedA notice about a lapse in government funding and related updates was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedNo significant additions or deletions were observed; the page content remains the same aside from minor UI tweaks and updated timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference3%

- Check98 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference0.4%

Stay in the know with updates to Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.